Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence-Reference-Cited by-同舟云学术

Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence

Published:2024-01 Issue:1 Volume:49 Page:102017
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Hajra Adrija^ORCID,Ujjawal Aditi,Ghalib Natasha,Chowdhury Selia,Biswas Suman,Balasubramanian Prasanth,Gupta Rahul,Aronow Wilbert S

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference55 articles.

1. Direct oral anticoagulant use: a practical guide to common clinical challenges;Chen;J Am Heart Assoc,2020

2. Non-vitamin K antagonist oral anticoagulants in medical conditions at high risk of thromboembolism beyond atrial fibrillation;Hong;J Stroke,2019

3. New direct oral anticoagulants (DOAC) and their use today;Schwarb;Dentist J,2016

4. Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010–2017;Zhu;Pharmacotherapy,2018

5. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial;Mega;Lancet,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis;Acta Neurologica Belgica;2024-07-10

2. Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis;Renal Failure;2024-05-21